Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Study affirms PhRMA's influence on physicians

John Dudley Miller

    Journal of the National Cancer Institute
    |July 27, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    After the anthrax.

    Scientific American·2008
    Same author

    Finding clinical meaning in cancer data.

    Journal of the National Cancer Institute·2007
    Same author

    Surviving side effects.

    Scientific American·2007
    Same author

    Conflict-of-interest spurs new rules, not consensus.

    Journal of the National Cancer Institute·2006
    Same author

    Contentious calculation.

    Scientific American·2006
    Same author

    Venous thromboembolism in long-distance air travellers.

    Lancet (London, England)·2004
    Same journal

    A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study.

    Journal of the National Cancer Institute·2026
    Same journal

    Response to Yu, Wang and Ge.

    Journal of the National Cancer Institute·2026
    Same journal

    Re: Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

    Journal of the National Cancer Institute·2026
    Same journal

    Welcome reduction of US cervical cancer rates despite state differences.

    Journal of the National Cancer Institute·2026
    Same journal

    Adjuvant dual HER2 blockade along the HER2-ER axis in APHINITY.

    Journal of the National Cancer Institute·2026
    Same journal

    Re: Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25).

    Journal of the National Cancer Institute·2026
    See all related articles